- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02890680
Effects of the Use of Platelet-rich Fibrin on Bone Regeneration After Impacted Third Molar Surgery
April 10, 2017 updated by: João Vitor dos Santos Canellas, DDS MS, Rio de Janeiro State University
Randomized Double Blind Clinical Trial Evaluation of Bone Regeneration After Impacted Third Molar Surgery With the of Platelet-rich Fibrin: Pilot Study
The purpose of this study is to evaluate the bone regeneration after impacted third molar surgery on split mouth design using platelet-rich fibrin.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Rio de Janeiro, Brazil, 24240170
- João Canellas
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 29 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy patients
- Preoperative platelet count higher than 150,00/ mm3
- Patient who required bilateral mandibular third molar extractions
Exclusion Criteria:
- Smokers patients
- Alcoholics patients
- Patients whom the inferior second molar was missing
- Patients who had acute pericoronitis on the inferior third molar
- Severe periodontal disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Platelet-rich fibrin group
Use platelet-rich fibrin after mandibular third molar extraction
|
|
Placebo Comparator: Control group
mandibular third molar extraction
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in bone density through tomography evaluation
Time Frame: Change from Baseline bone measurement at three months after surgery
|
Change from Baseline bone measurement at three months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in periodontal-probing depth measurement on distal aspect of the second molar through Clinical evaluation
Time Frame: Change from baseline at 3 months after surgery
|
Change from baseline at 3 months after surgery
|
Pain through Visual Analogue Scale
Time Frame: 1st day after surgery
|
1st day after surgery
|
Pain through Visual Analogue Scale
Time Frame: 3rd day after surgery
|
3rd day after surgery
|
Pain through Visual Analogue Scale
Time Frame: 7th day after surgery
|
7th day after surgery
|
Soft tissue healing through Clinical evaluation numeric scale
Time Frame: 7th day after surgery
|
7th day after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: João Vitor Canellas, DDS; MSc, Rio de Janeiro University State
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2016
Primary Completion (Actual)
November 1, 2016
Study Completion (Actual)
January 1, 2017
Study Registration Dates
First Submitted
August 24, 2016
First Submitted That Met QC Criteria
August 31, 2016
First Posted (Estimate)
September 7, 2016
Study Record Updates
Last Update Posted (Actual)
April 12, 2017
Last Update Submitted That Met QC Criteria
April 10, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CAAE 56621216.5.0000.5259
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Molar, Third
-
TriAgenics IncWithdrawn
-
Centre Hospitalier Universitaire de NīmesCompletedThird Molar ExtractionFrance
-
Fifth Affiliated Hospital of Guangzhou Medical...Not yet recruiting
-
I.M. Sechenov First Moscow State Medical UniversityNot yet recruitingImpacted Third Molar Tooth | Third Molar Extraction
-
University of CataniaCompletedImpacted Third Molar Tooth | Third Molar SurgeryItaly
-
University of Sao PauloCompleted
-
AB Biotics, SAHospital de Nens de BarcelonaCompletedSurgery--Complications | Molar, ThirdSpain
-
University of NaplesActive, not recruitingPostoperative Complications | Molar, ThirdItaly
-
Implantology InstituteRecruitingQuality of Life | Pain, Postoperative | Molar, Third | Third Molar Surgery | Soft Tissue SwellingPortugal
-
University of ZagrebCompleted
Clinical Trials on Control group
-
Tasly Pharmaceutical Group Co., LtdCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Henan Cancer HospitalRecruitingChemotherapy | Immune Checkpoint Inhibitor | Locally Advanced Gastric CarcinomaChina
-
International University of La RiojaRecruiting
-
The University of Hong Konghong Kong Cancer FundCompletedBreast Cancer | Yoga Therapy | Shoulder Joint Motion | Scar Contracture
-
Romanian Society of Anesthesia and Intensive CareUniversity of Medicine and Pharmacy "Victor Babes" Timisoara; Timişoara County...Completed
-
University of PernambucoUnknown
-
Yonsei UniversityUnknownAdvanced Gastric Cancer | Neoadjuvant Chemotherapy | Palliative ChemotherapyKorea, Republic of
-
Beijing Tiantan HospitalNot yet recruitingIschemic Stroke | Post-stroke Cognitive Impairment
-
Atatürk UniversityNot yet recruitingQuality of Life | Fatigue | Gestational Diabetes Mellitus in Pregnancy | Pregnancy in Diabetic